Proposed mechanism underlying the enhanced efficacy of co-administration of LCZ and lovastatin in the treatment of hyperlipidemia. (IMAGE)

Higher Education Press

Proposed mechanism underlying the enhanced efficacy of co-administration of LCZ and lovastatin in the treatment of hyperlipidemia.

Caption

The red up/down arrow next to a specific parameter indicates a relative increase or decrease in that parameter when the combination therapy is compared with low-dose lovastatin alone.

Credit

Bohai Li, Lai-Yu Kwok, Dandan Wang, Lu Li, Heping Zhang, Yongfu Chen

Usage Restrictions

Credit must be given to the creator. Only noncommercial uses of the work are permitted. No derivatives or adaptations of the work are permitted.

License

CC BY-NC-ND

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.